AG
Artal Group’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,005,610
| Closed | -$89.7M | – | 52 |
|
|
2024
Q2 | $89.7M | Sell |
3,005,610
-21,525
| -0.7% | -$643K | 2.29% | 4 |
|
|
2024
Q1 | $122M | Buy |
3,027,135
+496,400
| +20% | +$20M | 3.1% | 4 |
|
|
2023
Q4 | $64.4M | Buy |
2,530,735
+725,389
| +40% | +$18.5M | 2.14% | 7 |
|
|
2023
Q3 | $25.1M | Hold |
1,805,346
| – | – | 1.08% | 15 |
|
|
2023
Q2 | $41.5M | Hold |
1,805,346
| – | – | 1.29% | 13 |
|
|
2023
Q1 | $53.5M | Sell |
1,805,346
-194,654
| -10% | -$5.77M | 3.18% | 8 |
|
|
2022
Q4 | $49.9M | Buy |
2,000,000
+500,000
| +33% | +$12.5M | 2.79% | 9 |
|
|
2022
Q3 | $32.7M | Buy |
1,500,000
+500,000
| +50% | +$10.9M | 1.39% | 21 |
|
|
2022
Q2 | $19.7M | Hold |
1,000,000
| – | – | 1.05% | 21 |
|
|
2022
Q1 | $42.3M | Hold |
1,000,000
| – | – | 1.77% | 15 |
|
|
2021
Q4 | $63.5M | Buy |
1,000,000
+600,000
| +150% | +$38.1M | 1.72% | 13 |
|
|
2021
Q3 | $23.5M | Buy |
400,000
+150,000
| +60% | +$8.81M | 0.53% | 41 |
|
|
2021
Q2 | $12.1M | Hold |
250,000
| – | – | 0.25% | 76 |
|
|
2021
Q1 | $9.72M | Hold |
250,000
| – | – | 0.17% | 88 |
|
|
2020
Q4 | $15.5M | Hold |
250,000
| – | – | 0.33% | 62 |
|
|
2020
Q3 | $8.08M | Buy |
+250,000
| New | +$8.08M | 0.2% | 70 |
|